Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-27

FDA Approved: TECFIDERA — Original Application (Biogen Inc.)

View source ↗

Summary

FDA granted approval of Tecfidera (dimethyl fumarate) from Biogen for the treatment of relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tecfidera (dimethyl fumarate)

Snippet

ORIG AP for TECFIDERA (DIMETHYL FUMARATE)